231 related articles for article (PubMed ID: 24386498)
1. Detection of serotype-specific antibodies to the four dengue viruses using an immune complex binding (ICB) ELISA.
Emmerich P; Mika A; Schmitz H
PLoS Negl Trop Dis; 2013; 7(12):e2580. PubMed ID: 24386498
[TBL] [Abstract][Full Text] [Related]
2. Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody.
Wahala WM; Kraus AA; Haymore LB; Accavitti-Loper MA; de Silva AM
Virology; 2009 Sep; 392(1):103-13. PubMed ID: 19631955
[TBL] [Abstract][Full Text] [Related]
3. [Establishment and preliminary application of dengue virus envelope domain III IgG antibody capture enzyme-linked immuno-absorbent assay].
Hu DM; Cai JP; Wang DH; DI B; Qiu LW; Wang YD; Chen Y; Ding XX; Che XY
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Apr; 47(4):363-6. PubMed ID: 23928645
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera.
Batra G; Nemani SK; Tyagi P; Swaminathan S; Khanna N
BMC Infect Dis; 2011 Mar; 11():64. PubMed ID: 21401963
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1).
Gelanew T; Hunsperger E
Virol J; 2018 Feb; 15(1):30. PubMed ID: 29409531
[TBL] [Abstract][Full Text] [Related]
6. High performance dengue virus antigen-based serotyping-NS1-ELISA (plus): A simple alternative approach to identify dengue virus serotypes in acute dengue specimens.
Prommool T; Sethanant P; Phaenthaisong N; Tangthawornchaikul N; Songjaeng A; Avirutnan P; Mairiang D; Luangaram P; Srisawat C; Kasinrerk W; Vasanawathana S; Sriruksa K; Limpitikul W; Malasit P; Puttikhunt C
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009065. PubMed ID: 33635874
[TBL] [Abstract][Full Text] [Related]
7. Development of an Enzyme-Linked Immunosorbent Assay for Rapid Detection of Dengue Virus (DENV) NS1 and Differentiation of DENV Serotypes during Early Infection.
Lai SC; Huang YY; Shu PY; Chang SF; Hsieh PS; Wey JJ; Tsai MH; Ben RJ; Hsu YM; Fang YC; Hsiao ML; Lin CC
J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 30971466
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1).
Gelanew T; Poole-Smith BK; Hunsperger E
J Virol Methods; 2015 Sep; 222():214-23. PubMed ID: 26070890
[TBL] [Abstract][Full Text] [Related]
9. Assessment of diagnostic and analytic performance of the SD Bioline Dengue Duo test for dengue virus (DENV) infections in an endemic area (Savannakhet province, Lao People's Democratic Republic).
Blessmann J; Winkelmann Y; Keoviengkhone L; Sopraseuth V; Kann S; Hansen J; El Halas H; Emmerich P; Schmidt-Chanasit J; Schmitz H; Mika A; Deschermeier C
PLoS One; 2020; 15(3):e0230337. PubMed ID: 32182271
[TBL] [Abstract][Full Text] [Related]
10. A simple, inexpensive, robust and sensitive dot-blot assay for equal detection of the nonstructural-1 glycoprotein of all dengue virus serotypes.
Falconar AK; Romero-Vivas CM
Virol J; 2013 Apr; 10():126. PubMed ID: 23607292
[TBL] [Abstract][Full Text] [Related]
11. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
Nivarthi UK; Kose N; Sapparapu G; Widman D; Gallichotte E; Pfaff JM; Doranz BJ; Weiskopf D; Sette A; Durbin AP; Whitehead SS; Baric R; Crowe JE; de Silva AM
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031369
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.
Zidane N; Dussart P; Bremand L; Bedouelle H
BMC Infect Dis; 2013 Jul; 13():302. PubMed ID: 23815496
[TBL] [Abstract][Full Text] [Related]
13. Performance of Dengue Diagnostic Tests in a Single-Specimen Diagnostic Algorithm.
Hunsperger EA; Muñoz-Jordán J; Beltran M; Colón C; Carrión J; Vazquez J; Acosta LN; Medina-Izquierdo JF; Horiuchi K; Biggerstaff BJ; Margolis HS
J Infect Dis; 2016 Sep; 214(6):836-44. PubMed ID: 26984143
[TBL] [Abstract][Full Text] [Related]
14. A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.
Ramasamy V; Arora U; Shukla R; Poddar A; Shanmugam RK; White LJ; Mattocks MM; Raut R; Perween A; Tyagi P; de Silva AM; Bhaumik SK; Kaja MK; Villinger F; Ahmed R; Johnston RE; Swaminathan S; Khanna N
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006191. PubMed ID: 29309412
[TBL] [Abstract][Full Text] [Related]
15. Performance of commercial dengue NS1 ELISA and molecular analysis of NS1 gene of dengue viruses obtained during surveillance in Indonesia.
Aryati A; Trimarsanto H; Yohan B; Wardhani P; Fahri S; Sasmono RT
BMC Infect Dis; 2013 Dec; 13():611. PubMed ID: 24571329
[TBL] [Abstract][Full Text] [Related]
16. [Preparation and identification of neutralizing antibodies to envelope protein domain III(ED III) of the four dengue virus serotypes].
Ding X; Qiu L; Chen Y; Wen K
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Aug; 38(8):748-753. PubMed ID: 35851089
[TBL] [Abstract][Full Text] [Related]
17. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.
Chang SF; Huang JH; Chen LK; Su CL; Liao TL; Chien LJ; Lin TH; Su CJ; Shu PY
J Microbiol Immunol Infect; 2008 Oct; 41(5):377-85. PubMed ID: 19122918
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].
Ergünay K; Saygan MB; Aydoğan S; Litzba N; Niedrig M; Pınar A; Us D
Mikrobiyol Bul; 2010 Jul; 44(3):415-24. PubMed ID: 21063991
[TBL] [Abstract][Full Text] [Related]
19. Development of an antigen capture immunoassay based on monoclonal antibodies specific for dengue virus serotype 2 nonstructural protein 1 for early and rapid identification of dengue virus serotype 2 infections.
Qiu LW; Di B; Wen K; Wang XS; Liang WH; Wang YD; Pan YX; Wang M; Ding YQ; Che XY
Clin Vaccine Immunol; 2009 Jan; 16(1):88-95. PubMed ID: 19020106
[TBL] [Abstract][Full Text] [Related]
20. Serological tests reveal significant cross-reactive human antibody responses to Zika and Dengue viruses in the Mexican population.
Zaidi MB; Cedillo-Barron L; González Y Almeida ME; Garcia-Cordero J; Campos FD; Namorado-Tonix K; Perez F
Acta Trop; 2020 Jan; 201():105201. PubMed ID: 31562846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
